Identification of dominant anti-glycan IgE responses in school children by glycan microarray - 07/03/18
This study was supported by the European Academy of Allergy and Clinical Immunology Long-term Research Fellowship (E.K.A.-B.) for the project titled “Molecular Understanding of IgE cross-reactivity in Africa,” EuroPrevall (grant no. FOOD-CT-2005-514000), Global View of Food Allergy - GLOFAL (grant no. FOOD-CT-2005-517812), Wellcome Trust (grant no. 075791/Z/04/Z), and the Spanish Ministry of Economy and Competitiveness - MINECO (grant no. CTQ2014-58779-R). Funding bodies played no role in the design, collection, analysis, and interpretation of data or in the writing of the manuscript or the decision to submit it for publication. |
|
Disclosure of potential conflict of interest: A. S. Amoah has received a grant from the Wellcome Trust (grant no. 075791/Z/04/Z). E. K. Asuming-Brepong has received a grant from the European Academy of Allergy and Clinical Immunology. T. A. E. Platts-Mills has received a grant from the National Institute of Allergy and Infectious Disease and Phadia/Thermo Fisher, has received travel support from Phadia/Thermo Fisher, receives payment for a patent from the US Patent and Trademark Office, and has received royalties from IBT/Viracor. K. Brzezicka has received a grant from the Spanish Ministry of Economy and Competitiveness (MINECO, CTQ2011-27874 grant fellowship). D. A. Boakye has received grants from EuroPrevall (grant no. FOOD-CT-2005-514000) and GLOFAL (grant no. FOOD-CT-2005-517812). R. van Ree has consultant arrangements with HAL Allergy BV and Citeq BV; has received grants from the European Commission and the Dutch Science Foundation; and has received payment for lectures from HAL Allergy and ThermoFisher Scientific. M. Yazdanbakhsh has received grants from EuroPrevall (grant no. FOOD-CT-2005-514000) and GLOFAL (grant no. FOOD-CT-2005-517812) and has a board membership with the European Journal of Immunology. The rest of the authors declare that they have no relevant conflicts of interest. |
Vol 141 - N° 3
P. 1130-1133 - mars 2018 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?